Inventiva (IVA) Other Non Operating Income (2020 - 2021)

Inventiva's (IVA) quarterly Other Non Operating Income came in at $4.4 million in Q1 2021, up 40142.87% year-on-year from N/an in Q1 2020, and up 40142.87% quarter-over-quarter from $11039.4 in Q1 2020.

Inventiva (IVA) Other Non Operating Income (2020 - 2021) Analysis & Trends

Inventiva's Other Non Operating Income history runs 2 years deep, the most recent figure standing at $4.4 million for Q1 2021.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn
4 NuCana 279.75 Bn 279.75 Bn -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn
7 Belite Bio 62.51 Bn 62.51 Bn -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn -
10 Inventiva 842.48 Mn 842.48 Mn -

Historic Data

Download Data
DateValue
Mar 31, 2021 4.44 Mn
Mar 31, 2020 11,039.39